Logo

DiaSorin

DiaSorin Gets FDA 510(k) Clearance for Molecular CMV Test

The test, which runs on the company's Liaison MDx system, is designed for use with both saliva swab and urine specimens from newborns 21 days old or younger.

DiaSorin Q3 Revenues Dip 5 Percent as COVID-19 Test Sales Fall

The firm said revenue is still up for the first nine months year-over-year on strong non-COVID immunodiagnostics and molecular diagnostics sales.

DiaSorin Gets $31M BARDA Funding for Point-of-Care Instrument

The Italian firm said the Liaison NES will help improve access to testing for bacterial and viral diseases through an easy-to-use instrument running lower cost assays.

DiaSorin Gains FDA 510(k) Clearance for COVID-19 PCR Test

The assay is one of a few that have received full FDA clearance for COVID-19, which the agency has been encouraging companies to pursue.

DiaSorin Posts 32 Percent Jump in Q2 Revenues

The revenue growth was driven by higher sales of non-COVID-19 molecular diagnostic and immunodiagnostic products.

May 20, 2022

Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19

May 6, 2022

DiaSorin Q1 Revenues Rise 34 Percent Despite Dip in COVID-19 Test Demand

Mar 17, 2022

DiaSorin Expects 2022 Revenue Growth From Base Business, Luminex as COVID-19 Testing Declines
Premium

Mar 16, 2022

DiaSorin 2021 Revenues Rise 41 Percent on SARS-CoV-2, Luminex Sales Growth

Feb 1, 2022

Genetic Analysis Receives CE Mark for Microbiome Test on Luminex Magpix Instrument

Nov 11, 2021

DiaSorin Q3 Revenues Rise 51 Percent on Luminex Acquisition, Recovery of Non-COVID Test Sales

Sep 20, 2021

DiaSorin Molecular Receives CE Mark for Multiplex COVID-19, Influenza Test

Jul 30, 2021

DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand

May 14, 2021

DiaSorin Q1 Revenues Rise 53 Percent on SARS-CoV-2 Testing Demand

Apr 13, 2021

With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence
Premium

Apr 12, 2021

DiaSorin to Acquire Luminex for $1.8B

Feb 25, 2021

Luminex Shares Surge on Rumor of Acquisition by DiaSorin

Jan 13, 2021

BARDA Provides Additional Funding to DiaSorin Molecular for COVID-19 Tests

Sep 17, 2020

DiaSorin Receives CE Mark to Use Saliva Samples With COVID-19 Test

Sep 8, 2020

FDA Clears DiaSorin Test for Influenza, RSV

Jul 7, 2020

DiaSorin Molecular Gets CE Mark for Flu, RSV Assay

Jun 15, 2020

DiaSorin Molecular Gets CE Mark for Congenital CMV Assay

Apr 13, 2020

Coronavirus Tests From Seegene, DiaSorin, Others Get Health Canada Approval

Mar 20, 2020

Coronavirus Test From DiaSorin Molecular Gets FDA Emergency Use Authorization

Mar 13, 2020

DiaSorin Molecular Awarded $679K BARDA Funding to Develop Coronavirus Test

Breaking News
The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.